BioCentury This Week

Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns 01.02.2022 26:46 ↓

This week’s podcast is sponsored by ICON . Reach us by sending a text

Ep. 99 - Introducing The BioCentury Show, Plus Califf, COVID and GSK 25.01.2022 26:13 ↓

BioCentury’s new in-depth conversational series launches with Scott Gottlieb as debut guest. This week’s podcast is sponsored by ICON . Reach us by sending a text

Ep. 98 - Bargain Hunting in a Rocky Market, plus Advantage, CMS 19.01.2022 23:38 ↓

Part two of BioCentury’s 2022 Financial Markets Preview, access to Alzheimer’s mAbs, and translational highlights from the Distillery. This week’s podcast is sponsored by ICON . Reach us by sending a text

Ep. 97 - Buysiders' Picks, plus JPM22 roundup 11.01.2022 27:38 ↓

Reach us by sending a text

Ep. 96 - Aduhelm, Pazdur, Pharma Digital & '21 Wrap 21.12.2021 23:19 ↓

Reach us by sending a text

Ep. 95 - ASH's New Targets, Avistone & Washington Update 14.12.2021 19:36 ↓

Reach us by sending a text

Ep. 94 - Woodcock's To-Do List, Maraganore's Takeaways & the Distillery 07.12.2021 22:45 ↓

Reach us by sending a text

Ep. 93 - Omicron's Open Questions, Plus the Business Case for Ultra-rare Diseases 30.11.2021 19:54 ↓

Reach us by sending a text

Ep. 92 - Biogen’s R&D decision, previewing TIGIT & China Summit highlights 22.11.2021 23:13 ↓

Reach us by sending a text

Ep. 91 - China Summit Highlights: Day 2 18.11.2021 38:30 ↓

Reach us by sending a text

Ep. 90 - China Summit Highlights: Day 1 17.11.2021 36:05 ↓

Reach us by sending a text

Ep. 89 - Califf's Passions, RWE in China & LSP Rising 16.11.2021 32:57 ↓

Reach us by sending a text

Ep. 88 - China Summit Preview: The Bridge to Innovation 10.11.2021 28:14 ↓

Reach us by sending a text

Ep. 87 - Digesting Drug Pricing, Plus Access in ALS 09.11.2021 32:41 ↓

Reach us by sending a text

Ep. 86 - Woodcock's Legacy, Plus Frazier, Bain & the Distillery 02.11.2021 26:56 ↓

Reach us by sending a text

Ep. 85 - What's Next for CRISPR & Gene Therapy, Plus China Summit Preview 26.10.2021 23:28 ↓

Reach us by sending a text

Ep. 84 - Why Gene Therapy's Bad Year Is a Speed Bump, Not a Dead End 22.10.2021 23:08 ↓

Reach us by sending a text

Ep. 83 - Assessing Biogen’s ALS Miss, Plus Califf on Deck 18.10.2021 23:08 ↓

Reach us by sending a text

Ep. 82 - 4Q Markets Preview, Plus the Future of NIH 12.10.2021 30:34 ↓

Reach us by sending a text

Ep. 81 - Merck & the State of M&A, Plus Novartis CEO's Call to Action 05.10.2021 22:25 ↓

Reach us by sending a text

Ep. 80 - Hong Kong Rising, Plus Varmus' POV & Biden's FDA Choice 28.09.2021 27:25 ↓

Reach us by sending a text

Ep. 79 - ESMO, Jeito & the Latest from Washington 21.09.2021 23:21 ↓

Reach us by sending a text

Ep. 78 - Remembering Fred Frank, Lisa Raines, Plus CRISPR, Washington Updates 14.09.2021 27:01 ↓

Reach us by sending a text

Ep. 77 - Back to School Spotlight & Pressures on FDA 04.09.2021 22:17 ↓

Reach us by sending a text

Ep 76 Pt. 4 - Modifying Access for Accelerated Approvals 01.09.2021 13:43 ↓

Reach us by sending a text